The present invention provides preparations useful in an improved method to deliver estrogen to menopausal women comprising administering, either intermittently or pulsed, ultra-low dose estradiol alternating with standard-dose estradiol. These preparations may be used to normalize ER vascular responses and restore the protective effects of estrogen replacement on the cardiovascular system.